Viking Therapeutics (VKTX) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for Viking Therapeutics (VKTX) over the last 7 years, with Sep 2025 value amounting to -$1.1 million.
- Viking Therapeutics' Other Gross PP&E Adjustments rose 33.66% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.1 million, marking a year-over-year increase of 13.35%. This contributed to the annual value of -$1.5 million for FY2024, which is 1.26% down from last year.
- Viking Therapeutics' Other Gross PP&E Adjustments amounted to -$1.1 million in Q3 2025, which was up 9.52% from -$1.2 million recorded in Q2 2025.
- In the past 5 years, Viking Therapeutics' Other Gross PP&E Adjustments ranged from a high of -$188,000 in Q3 2021 and a low of -$1.9 million during Q2 2022.
- Over the past 3 years, Viking Therapeutics' median Other Gross PP&E Adjustments value was -$1.5 million (recorded in 2023), while the average stood at -$1.5 million.
- In the last 5 years, Viking Therapeutics' Other Gross PP&E Adjustments soared by 74.42% in 2021 and then crashed by 887.77% in 2022.
- Over the past 5 years, Viking Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$383,000 in 2021, then slumped by 366.32% to -$1.8 million in 2022, then grew by 15.73% to -$1.5 million in 2023, then declined by 1.26% to -$1.5 million in 2024, then surged by 33.66% to -$1.1 million in 2025.
- Its Other Gross PP&E Adjustments was -$1.1 million in Q3 2025, compared to -$1.2 million in Q2 2025 and -$1.3 million in Q1 2025.